South Korea vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Immunization, measles

South Korea
97.0%
in 2024
Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
83.6%
in 2024
South Korea rank
31st
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank
28th

Immunization, measles over time

  • South Korea
  • Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
020406080100198020022024

How they compare

South Korea currently reports 97.0% against 83.6% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 13.4%.

That makes South Korea's figure about 1.2 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.

The two have swapped places 1 time across 45 shared years of data; in 1980 it was Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ahead.

South Korea ranks 31st and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 28th of 193 countries.

South Korea has averaged higher in every one of the 5 decades both report.

Head to head by decade

Decade South Korea Middle East, North Africa, Afghanistan & Pakistan (excluding high income) Difference Ahead
1980s 53.3% 40.3% 13.0% South Korea
1990s 90.5% 69.6% 20.9% South Korea
2000s 95.8% 73.9% 21.9% South Korea
2010s 98.3% 79.4% 18.9% South Korea
2020s 97.4% 82.3% 15.1% South Korea

Averages of every year both report within each decade.

Frequently asked questions

Which has higher immunization, measles, South Korea or Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
South Korea, at 97.0% against 83.6% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2024.
What is the difference in immunization, measles between South Korea and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
13.4%, with South Korea ahead.
How many years of comparable data are there for South Korea and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
45 years are reported by both, from 1980 to 2024.
How do South Korea and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank globally for immunization, measles?
South Korea ranks 31st and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 28th of 193 countries.
Where does this data come from?
World Health Organization (WHO), published as Immunization, measles (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

South Korea vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Immunization, measles. Statizoid, drawing on World Health Organization (WHO). Retrieved 19 September 2026, from https://health.statizoid.com/compare/immunization-measles-percent-of-children-ages-12-23-months/korea-rep/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/immunization-measles-percent-of-children-ages-12-23-months/korea-rep/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/">South Korea vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Immunization, measles</a> — Statizoid

About this data

Indicator
Immunization, measles (% of children ages 12-23 months)
Unit
% of children ages 12-23 months
Source
World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
240 places, 10,001 data points, 1980–2024
Last refreshed

Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.